Study guide
3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions
NABP MPJE Multistate Pharmacy Jurisprudence Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pharmacist Licensure & Reciprocity
1.1 Initial Licensure Requirements & Examinations 1.2 License Renewal, Continuing Education (CE) & Status 1.3 Reciprocity, License Transfer & Multistate Licensure 1.4 Disciplinary Actions, Board Hearings, Sanctions & Reinstatement
2 Chapter 2: Pharmacy Personnel Roles & Supervision Ratios
2.1 Pharmacy Interns: Scope of Practice, Supervision & Preceptor Rules 2.2 Pharmacy Technicians: Registration, Certification & Permitted Duties 2.3 Technician-to-Pharmacist Ratios & Delegated Tasks 2.4 Non-Pharmacist Personnel & Automated Dispensing Technology Roles
3 Chapter 3: Prescriptive Authority & Practitioner Categories
3.1 Physicians, Dentists, Veterinarians & Podiatrists: Prescribing Scope 3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority 3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions 3.4 Self-Prescribing & Prescribing for Family Members
4 Chapter 4: Patient Counseling & Drug Utilization Review (OBRA '90)
4.1 OBRA '90 Mandates & Prospective Drug Utilization Review (DUR) 4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation 4.3 Patient Profile Requirements & Retrospective DUR
5 Chapter 5: Advanced Pharmacist Practice & Collaborative Agreements
5.1 Collaborative Practice Agreements (CPAs) & Protocol-Based Care 5.2 Pharmacist Immunization Authority & Vaccine Administration Protocols 5.3 Medication Therapy Management (MTM) & Point-of-Care Testing (POCT) 5.4 Hormonal Contraceptive, Naloxone & Post-Exposure Prophylaxis (PEP/PrEP) Prescribing
6 Chapter 6: Federal Controlled Substances Act (CSA) & Scheduling
6.1 Controlled Substance Schedules (CI through CV) & Classification Criteria 6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles 6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)
7 Chapter 7: Controlled Substance Prescriptions & Legitimate Purpose
7.1 Corresponding Responsibility & Red Flags for Improper Prescribing 7.2 Required Components of Controlled Substance Prescriptions 7.3 Electronic Prescriptions for Controlled Substances (EPCS) & Security Requirements 7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)
8 Chapter 8: Controlled Substance Ordering, Inventory & Recordkeeping
8.1 Ordering Schedule II Substances: CSOS & DEA Form 222 Execution 8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness) 8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41) 8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)
9 Chapter 9: Federal Pure Food, Drug & Cosmetic Act (FD&C Act) & Drug Safety
9.1 Adulteration vs. Misbranding: Statutory Definitions & Legal Violations 9.2 Prescription Labeling Requirements, Expiration Dates & Side Effect Statements 9.3 Poison Prevention Packaging Act (PPPA) & Child-Resistant Container Exemptions 9.4 Drug Recalls (Class I, II, III) & Market Withdrawals 9.5 Drug Product Selection, Generic Substitution & DAW Codes 9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs
10 Chapter 10: Drug Supply Chain Security Act (DSCSA) & Commercial Distribution
10.1 DSCSA Track-and-Trace Requirements: Transaction Information & Statements 10.2 Suspect & Illegitimate Product Verification, Quarantine & Notification 10.3 Prescription Drug Marketing Act (PDMA): Samples, Reimportation & Wholesale Distribution
11 Chapter 11: Compounding Standards: USP <795>, <797> & <800>
11.1 Section 503A vs. 503B Compounding Facilities (DQSA Architecture) 11.2 Non-Sterile Compounding (USP <795>) & Beyond-Use Dating (BUD) 11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD 11.4 Hazardous Drug Handling (USP <800>): Engineering Controls & Personal Protective Equipment
12 Chapter 12: Pharmacy Operational Security, Records & Telepharmacy
12.1 Physical Pharmacy Security, Alarm Systems & Keyholder Rules 12.2 Mandatory Pharmacy Records Retention & Audit Inspection Readiness 12.3 Central Fill, Automated Dispensing Systems (ADS) & Telepharmacy Operations 12.4 HIPAA Privacy Rule, Patient Records & Breach Notification Protocols
3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions
Key Takeaways Explain This Topic AI
Non-controlled prescriptions written by out-of-state prescribers are valid nationwide, provided the practitioner is licensed and acting within scope in their home state.
Controlled substance prescriptions from out-of-state practitioners require active home-state DEA registration and compliance with both dispensing-state and prescribing-state laws.
Prescriptions written by practitioners in foreign countries are generally invalid for controlled substances; non-controlled foreign validity depends on explicit state law exceptions.
Practitioner death, license revocation, or retirement immediately terminates the prescriber-patient relationship, rendering remaining refills legally invalid unless state law provides a specific grace period.
Telemedicine prescriptions for controlled substances must comply with federal Ryan Haight Act in-person medical evaluation rules and state telehealth registration standards.
Last updated: July 2026
3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions
Pharmacy practice frequently involves prescriptions originating outside the local jurisdiction, including prescriptions from out-of-state physicians, foreign prescribers, telemedicine providers, or practitioners who have recently died or retired. Understanding the statutory rules governing prescription validity across these scenarios is critical for MPJE success.
Out-of-State Prescriptions (U.S. States & Territories)
Under principles of interstate commerce and state pharmacy practice acts, prescriptions written by practitioners licensed in another U.S. state, district, or territory (e.g., Puerto Rico, Guam, U.S. Virgin Islands) are generally fillable, but key distinctions exist between non-controlled and controlled substances .
1. Out-of-State Non-Controlled Substances
General Rule : Prescriptions for non-controlled legend drugs written by an out-of-state physician (MD/DO), dentist, podiatrist, or veterinarian are valid and may be dispensed by a community pharmacy.
Verification Duty : The pharmacist must confirm that:
The practitioner holds a valid, active license in their home jurisdiction.
The prescription was issued within the practitioner's lawful scope of practice.
A legitimate patient-prescriber relationship exists.
2. Out-of-State Controlled Substances (Schedules II–V)
Dispensing out-of-state controlled substance prescriptions involves dual compliance with federal regulations and state-specific MPJE statutes:
Federal DEA Requirement : The out-of-state prescriber must hold an active DEA registration in the state where they practice.
State MPJE Nuances : State laws vary significantly regarding out-of-state controlled substances:
Permissive States : Allow any valid out-of-state controlled substance prescription if the prescriber is registered with the DEA.
Restrictive States : Limit Schedule II out-of-state prescriptions to contiguous states, require the prescriber to be registered with the local state Prescription Monitoring Program (PMP), or require prescriptions to be issued on official state tamper-resistant prescription paper.
Telemedicine & Out-of-State CS Prescribing : Under the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 , issuing a controlled substance prescription via telemedicine requires at least one in-person medical evaluation of the patient, unless a specific federal emergency waiver or statutory exception applies. Prescriptions issued following purely online questionnaires without an in-person exam are illegal .
Foreign Country Prescriptions
Prescriptions originating from foreign countries (e.g., Canada, Mexico, Europe, Asia) raise distinct federal and state legal barriers.
1. Foreign Controlled Substances
Strictly Prohibited : It is unlawful under the federal Controlled Substances Act for a U.S. pharmacy to dispense a controlled substance prescription written by a foreign practitioner.
Reasoning : Foreign practitioners do not hold a U.S. state medical license or an active DEA registration. A DEA registration cannot be issued to a practitioner without a valid U.S. state license.
2. Foreign Non-Controlled Substances
Federal Importation Laws : Federal law generally prohibits the importation of non-FDA approved foreign pharmaceuticals and restricts cross-border prescribing.
State Law Exemptions : State pharmacy acts dictate whether foreign non-controlled prescriptions may be filled locally:
General State Rule : Most states consider foreign prescriptions invalid because the foreign prescriber lacks licensure within a U.S. state or territory.
Border State Exceptions : Select states (e.g., Texas, Florida, Arizona) have specific statutory provisions permitting pharmacists to fill non-controlled prescriptions written by physicians licensed in Canada or Mexico , provided the pharmacist verifies practitioner credentials and dispenses an FDA-approved drug product.
Deceased, Retired, Suspended, or Surrendered Practitioners
When a prescribing practitioner dies, retires, surrenders their license, or has their license revoked/suspended by a state board, the legal status of their outstanding prescriptions and unfulfilled refills changes immediately.
The Legal Principle: Termination of Prescriber-Patient Relationship
A valid prescription requires an active, ongoing practitioner-patient relationship. Upon the death, license revocation, or retirement of a practitioner, the practitioner-patient relationship is legally terminated . Consequently, all unfulfilled prescriptions and remaining refills written by that practitioner legally lose their validity.
Strict Law vs. State Grace Period Nuances
Strict Federal / Statutory View : The moment a practitioner dies or loses their license, their prescriptions and refills become void immediately . Dispensing a refill after the date of death is technically dispensing without a valid prescription.
State MPJE Grace Periods : Recognizing patient access disruption, many state pharmacy boards enact statutory grace periods for non-controlled legend drugs :
Standard Grace Period : A pharmacist may fill or refill a non-controlled prescription for a 30-day supply (or up to 60/90 days depending on state law) following the practitioner's death or retirement, allowing the patient reasonable time to establish care with a new physician.
Emergency Refill Rule : In states without explicit grace periods, pharmacists may utilize emergency fill statutes to supply up to a 30-day non-controlled supply if withholding medication would endanger patient health.
Schedule II Controlled Substances : Grace periods NEVER apply to Schedule II controlled substances . Upon practitioner death, retirement, or license loss, all Schedule II prescriptions become immediately void and cannot be filled under any circumstances.
Summary Table: Prescription Validity Matrix
Prescriber Category Non-Controlled Drugs Controlled Substances (Sch III–V) Controlled Substances (Sch II) Key Legal Conditions
Out-of-State U.S. Practitioner Valid Nationwide Valid (Requires DEA & State Rules) Valid (Check State Restrictive Laws) Practitioner must be actively licensed in home state.
Foreign Practitioner (Canada/Mexico) State-Dependent (Invalid in most; valid in border states) INVALID INVALID Foreign prescribers lack DEA registration.
Deceased Practitioner Void (or valid up to 30–90 day state grace period) Void (Strict scrutiny / Limited grace) IMMEDIATELY VOID Prescriber-patient relationship terminated.
Retired / Suspended Practitioner Void (State emergency supply may apply) INVALID INVALID License inactive; no legal prescribing authority.